131 related articles for article (PubMed ID: 9123408)
1. Effect of prostaglandin I2 analogue and thromboxane A2 synthetase inhibitor on chronic rejection in rats.
Hirano T; Nakafusa Y; Nishinaka H; Takeda K; Kawano R; Nakano M; Arima T; Motoyama K; Nakamura K; Torada N; Ikematsu H; Kamei T; Tanaka M
Transplant Proc; 1997; 29(1-2):1520. PubMed ID: 9123408
[No Abstract] [Full Text] [Related]
2. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
3. Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
Tanabe K; Toma H; Sagara R; Takahashi K; Teraoka S; Ota K
Transplant Proc; 1989 Feb; 21(1 Pt 1):293-5. PubMed ID: 2650124
[No Abstract] [Full Text] [Related]
4. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
5. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Iida T; Yokoi H; Kawarada Y
Pancreas; 1998 Aug; 17(2):140-7. PubMed ID: 9700944
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the effects of cyclosporine and FK 506 on the progress of chronic rejection in the rat aortic model.
Cole OJ; Stubington SR; Rigg KM; Shehata M
Transplant Proc; 1998 Jun; 30(4):991. PubMed ID: 9636400
[No Abstract] [Full Text] [Related]
7. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I
Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
[No Abstract] [Full Text] [Related]
8. Histopathologic changes during chronic small bowel allograft rejection.
Klaus A; Offner F; Klima G; Margreiter R; Pernthaler H
Transplant Proc; 1998 Sep; 30(6):2586. PubMed ID: 9745500
[No Abstract] [Full Text] [Related]
9. Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
Walgenbach KJ; Heeckt PF; Stanson JD; Whiteside TL; Bauer AJ
Transplant Proc; 1996 Oct; 28(5):2454. PubMed ID: 8907896
[No Abstract] [Full Text] [Related]
10. [The effects of thromboxane A2 synthetase inhibitor on chronic rejection of kidney transplantation].
Imanishi M; Ikegami M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):895-901. PubMed ID: 2402113
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cytologic examination of luminal exudate in monitoring acute rejection of rat intestinal allografts.
Rahman MS; Taguchi T; Masumoto K; Guo R; Nakao M; Yanai K; Suita S; Nada O; Ohta M
Transplant Proc; 1998 Sep; 30(6):2653. PubMed ID: 9745534
[No Abstract] [Full Text] [Related]
12. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A
Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
[No Abstract] [Full Text] [Related]
13. Protective effect of pyruvate during acute rejection of intestinal allografts: accompanied by up-regulation of inducible nitric oxide synthase mRNA.
Cicalese L; Hierholzer C; Subbotin V; Iyengar A; Rao AS; Stanko RT
Transplant Proc; 1997 May; 29(3):1813-4. PubMed ID: 9142283
[No Abstract] [Full Text] [Related]
14. Immunohistochemical analysis in the extracellular matrix during acute rejection of small bowel grafts in rats.
Fujisaki S; Kimizuka K; Park E; Tomita R; Fukuzawa M; Matsumoto K
Transplant Proc; 2000 Sep; 32(6):1316-7. PubMed ID: 10995964
[No Abstract] [Full Text] [Related]
15. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
Hatziantoniou C; Papanikolaou N
Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
[TBL] [Abstract][Full Text] [Related]
16. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
Hare GM; Lee TD; Jordan JL; Hirsch GM
Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
[No Abstract] [Full Text] [Related]
17. Inhibition of graft arteriosclerosis by modulation of the inflammatory response.
Adams DH; Wyner LR; Steinbeck MJ; Karnovsky MJ
Transplant Proc; 1993 Apr; 25(2):2092-4. PubMed ID: 8470282
[No Abstract] [Full Text] [Related]
18. Met-RANTES improves acute-rejection-induced microvascular injury in rat small bowel transplantation.
Bedke J; Stojanovic T; Gröne HJ; Heuser M; Scheele L; Proudfoot AE; Becker H; Markus PM; Hecker M
Transplant Proc; 2002 May; 34(3):1049. PubMed ID: 12034300
[No Abstract] [Full Text] [Related]
19. In vivo changes in acute rejection of rat small bowel allografts.
Stojanovic T; Schlemminger R; Bedke J; Gröne HJ; Heuser M; Leister I; Hecker M; Becker H; Markus PM
Transplant Proc; 2000 Sep; 32(6):1247-8. PubMed ID: 10995931
[No Abstract] [Full Text] [Related]
20. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
